Mutation analysis of CD95 (APO-1/Fas) in childhood B-lineage acute lymphoblastic leukaemia

Br J Haematol. 1998 Aug;102(3):722-8. doi: 10.1046/j.1365-2141.1998.00827.x.

Abstract

The CD95 system plays an important role in lymphocyte homeostasis, has been implicated in the development of lymphoid malignancies, exerts a tumour suppressor function, and contributes to drug-induced cytotoxicity. We hypothesized that mutations of CD95 may occur in childhood B-lineage acute lymphoblastic leukaemia (ALL), a disease known for its constitutive resistance towards CD95-mediated apoptosis. We investigated 32 primary B-lineage ALL of childhood and five B-lineage ALL cell lines. All primary leukaemias expressed CD9 5 and bcl-2 to a variable degree. Most of the leukaemias were resistant towards CD95-mediated apoptosis. However, using SSCP analysis, no mutations in the coding and proximal promoter region could be detected. We conclude that the resistance towards CD95-mediated apoptosis observed in most de novo B-lineage ALL is not caused by mutations of the CD95 death receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / genetics
  • Base Sequence
  • Burkitt Lymphoma / genetics*
  • Burkitt Lymphoma / metabolism
  • Child
  • DNA Mutational Analysis
  • Genes, bcl-2 / genetics
  • Humans
  • Molecular Sequence Data
  • Mutation*
  • Polymorphism, Single-Stranded Conformational
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics*
  • Promoter Regions, Genetic / genetics
  • Tumor Cells, Cultured
  • fas Receptor / genetics*
  • fas Receptor / metabolism

Substances

  • fas Receptor